Clinical relevance of F-18 -FDG PET/CT in the follow-up of patients with operated medullary thyroid cancer. Is there any additional value of other radionuclide methods?

FDG PET/CT in medullary cancer

Authors

  • Jelena Saponjski
  • Dragana Sobic Saranovic
  • Djuro Macut
  • Branislava Radovic
  • Vera Artiko

Abstract

Objective: The aim is evaluation of 18F-FDG PET/CT in the detection of active disease in the patients with suspected recurrence of the medullary thyroid carcinoma (MTC).

Methods: 18F-FDG PET/CT investigation was performed in 67 patients. Additionally, 25 underwent 99mTc-DMSA scintigraphy, 11 underwent somatostatin receptor scintigraphy (SRS) with 99mTc- HYNIC TOC while 11 123I-MIBG scintigraphy.

Results: From 67 patients, 35 (52.2%) had true positive 18F-FDG PET/CT findings (TP). Average standardized uptake value (SUVmax) for all TP lesions was 5.01 + 3.6. In 25 (37.3%) patients findings were true negative  (TN). Four (6%) patients had false positive (FP) findings while three (4.5%) were false negative (FN). Thus, sensitivity of the 18F-FDG PET/CT was 92.11%, specificity 86.21%, positive predictive value 89.74%, negative predictive value 89.29% and accuracy 89.55%.  In 27 patients (40%) 18F-FDG PET/CT finding influenced further management of the patient. 

Conclusion: 18F-FDG PET/CT has high accuracy in the detection of metastases/recurrences of MTC in patients after thyroidectomy as well as in evaluation and the appropriate choice of the therapy. 

Downloads

Published

2021-02-15

How to Cite

Saponjski, J., Saranovic, D., Macut, D., Radovic, B., & Artiko, V. (2021). Clinical relevance of F-18 -FDG PET/CT in the follow-up of patients with operated medullary thyroid cancer. Is there any additional value of other radionuclide methods? : FDG PET/CT in medullary cancer. Radiology and Oncology, 55(1), 18–25. Retrieved from https://www.radioloncol.com/index.php/ro/article/view/3529

Issue

Section

Nuclear medicine